| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 171.76B | 159.65B | 141.91B | 132.36B | 109.77B |
| Gross Profit | 47.14B | 42.75B | 37.21B | 35.64B | 31.02B |
| EBITDA | 27.12B | 23.90B | 19.52B | 18.14B | 15.77B |
| Net Income | 15.60B | 13.89B | 12.16B | 11.02B | 8.55B |
Balance Sheet | |||||
| Total Assets | 223.93B | 199.22B | 187.46B | 167.79B | 155.49B |
| Cash, Cash Equivalents and Short-Term Investments | 43.34B | 51.92B | 46.93B | 39.87B | 39.59B |
| Total Debt | 9.21B | 10.42B | 18.90B | 25.91B | 29.87B |
| Total Liabilities | 62.14B | 55.34B | 62.77B | 62.01B | 63.65B |
| Stockholders Equity | 161.28B | 143.37B | 124.14B | 105.08B | 91.23B |
Cash Flow | |||||
| Free Cash Flow | 7.42B | 14.88B | 9.24B | 4.62B | 2.18B |
| Operating Cash Flow | 17.77B | 20.54B | 13.49B | 12.94B | 9.71B |
| Investing Cash Flow | -19.45B | -11.81B | -5.28B | -9.61B | -8.65B |
| Financing Cash Flow | -5.68B | -7.80B | -7.05B | -7.01B | -6.62B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥174.90B | 11.62 | 10.24% | 2.43% | 7.59% | 9.69% | |
77 Outperform | ¥141.46B | 21.73 | ― | 1.79% | 7.03% | 26.11% | |
74 Outperform | ¥110.94B | 16.59 | ― | 2.66% | 0.19% | 9.62% | |
69 Neutral | ¥767.85B | 16.33 | 27.58% | 0.99% | 8.43% | 225.40% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | ¥1.59T | 20.78 | 3.37% | 1.85% | 0.85% | 8.37% | |
54 Neutral | ¥108.17B | 233.67 | 2.80% | 3.38% | -4.52% | -91.68% |